These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15121324

  • 1. Control without separate controls: evaluation of vaccine safety using case-only methods.
    Farrington CP.
    Vaccine; 2004 May 07; 22(15-16):2064-70. PubMed ID: 15121324
    [Abstract] [Full Text] [Related]

  • 2. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.
    Pediatrics; 2008 Dec 07; 122(6):e1179-85. PubMed ID: 19047220
    [Abstract] [Full Text] [Related]

  • 3. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug 07; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 07; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.
    Pediatrics; 2006 Sep 07; 118(3):e602-9. PubMed ID: 16950952
    [Abstract] [Full Text] [Related]

  • 10. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.
    Arch Pediatr Adolesc Med; 2005 Dec 07; 159(12):1136-44. PubMed ID: 16330737
    [Abstract] [Full Text] [Related]

  • 11. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.
    Pediatrics; 2005 Jun 07; 115(6):1675-84. PubMed ID: 15930232
    [Abstract] [Full Text] [Related]

  • 12. Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake.
    Skowronski DM, Pielak K, Remple VP, Halperin BA, Patrick DM, Naus M, McIntyre C.
    Vaccine; 2004 Dec 02; 23(3):353-61. PubMed ID: 15530680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 02; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 15. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S.
    Am J Manag Care; 2007 Sep 02; 13(9):506-12. PubMed ID: 17803364
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul 02; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.
    Meriste S, Lutsar I, Tamm E, Willems P.
    Scand J Infect Dis; 2006 Jul 02; 38(5):350-6. PubMed ID: 16709537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group.
    Pediatrics; 2009 Jan 02; 123(1):301-12. PubMed ID: 19117896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.